{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T19:22:06Z","timestamp":1768677726700,"version":"3.49.0"},"reference-count":30,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective:<\/jats:title>\n                  <jats:p>The mechanism of the beneficial effect of calcium-channel blockers (CCBs), especially verapamil, on the development of type 2 diabetes mellitus (T2DM) has been described. This study compared the incidence of T2DM in adults prescribed oral verapamil and propensity score\u2013matched adults prescribed other oral CCBs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods:<\/jats:title>\n                  <jats:p>This retrospective population-based cohort study used Taiwan\u2019s National Health Insurance Research Database from 2000 to 2011. T2DM was defined according to the International Classification of Diseases, Ninth Revision, Clinical Modification.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>During follow-up periods of 41,958 and 42,118 person-years, 269 of 4930 patients in the verapamil cohort and 340 of 4930 patients in the matched cohort, respectively, developed T2DM. The incidence rates were 6.41 and 8.07 per 1000 population per year among verapamil and other CCB users, respectively. The adjusted hazard ratio (HR) for T2DM associated with use of verapamil (vs. other CCBs) was 0.80 [95% confidence interval (CI), 0.68 to 0.94; P = 0.006]. After exclusion of patients followed for &amp;lt;180 days or &amp;lt;365 days (to avoid bias derived from delayed diagnosis), adjusted HRs remained significant [0.79 (95% CI, 0.67 to 0.93; P = 0.005) and 0.77 (95% CI, 0.65 to 0.91; P = 0.002), respectively]. Only the interaction term for age was significant (P = 0.009). Verapamil had a more prominent effect on patients aged older than 65 years (P &amp;lt; 0.001).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>In patients with no known history of diabetes mellitus, oral verapamil use was associated with a decreased incidence of T2DM compared with other CCBs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2016-3778","type":"journal-article","created":{"date-parts":[[2017,7,6]],"date-time":"2017-07-06T18:00:11Z","timestamp":1499364011000},"page":"2604-2610","source":"Crossref","is-referenced-by-count":43,"title":["Verapamil Use Is Associated With Reduction of Newly Diagnosed Diabetes Mellitus"],"prefix":"10.1210","volume":"102","author":[{"given":"Ti","family":"Yin","sequence":"first","affiliation":[{"name":"Department of Nursing, Tri-Service General Hospital, Taipei 114, Taiwan"},{"name":"Department of Nursing, National Defense Medical Center, Taipei 114, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Chen","family":"Kuo","sequence":"additional","affiliation":[{"name":"National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli County 350, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yea-Yuan","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, National Yang Ming University Hospital, Yilan 260, Taiwan"},{"name":"Division of Infectious Diseases, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei 112, Taiwan"},{"name":"Institute of Clinical Medicine, National Yang Ming University, Taipei 112, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Tai","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, National Yang Ming University, Taipei 112, Taiwan"},{"name":"Department of Nephrology, Taipei City Hospital, Heping Fuyou Branch, Taipei 100, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Wei Katherine","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nursing, Mackay Medical College, New Taipei 252, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2017,3,24]]},"reference":[{"issue":"5","key":"2020071619322526200_B1","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"issue":"4","key":"2020071619322526200_B2","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2337\/dc12-2625","article-title":"Economic costs of diabetes in the U.S. in 2012","volume":"36","author":"American Diabetes Association","year":"2013","journal-title":"Diabetes Care"},{"issue":"6","key":"2020071619322526200_B3","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"2020071619322526200_B4","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2337\/diacare.28.3.736","article-title":"A systematic review of drug therapy to delay or prevent type 2 diabetes","volume":"28","author":"Padwal","year":"2005","journal-title":"Diabetes Care"},{"issue":"4","key":"2020071619322526200_B5","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2337\/db11-0955","article-title":"Preventing \u03b2-cell loss and diabetes with calcium channel blockers","volume":"61","author":"Xu","year":"2012","journal-title":"Diabetes"},{"issue":"7","key":"2020071619322526200_B6","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.amjcard.2006.04.030","article-title":"Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST])","volume":"98","author":"Cooper-Dehoff","year":"2006","journal-title":"Am J Cardiol"},{"issue":"5","key":"2020071619322526200_B7","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.ahj.2005.05.024","article-title":"Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients--findings from the International Verapamil SR\/Trandolapril Study (INVEST)","volume":"151","author":"Cooper-DeHoff","year":"2006","journal-title":"Am Heart J"},{"key":"2020071619322526200_B8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.diabres.2016.01.021","article-title":"Calcium channel blocker use is associated with lower fasting serum glucose among adults with diabetes from the REGARDS study","volume":"115","author":"Khodneva","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"2020071619322526200_B9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/jama.278.2.89","article-title":"The effect of universal health insurance on health care utilization in Taiwan. Results from a natural experiment","volume":"278","author":"Cheng","year":"1997","journal-title":"JAMA"},{"issue":"6","key":"2020071619322526200_B10","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"2020071619322526200_B11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/cid\/cit708","article-title":"Association between recent use of fluoroquinolones and rhegmatogenous retinal detachment: a population-based cohort study","volume":"58","author":"Kuo","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"20","key":"2020071619322526200_B12","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","article-title":"Azithromycin and the risk of cardiovascular death","volume":"366","author":"Ray","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"2020071619322526200_B13","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2337\/dc12-0473","article-title":"Population-based cohort analyses of the bidirectional relationship between type 2 diabetes and depression","volume":"36","author":"Chen","year":"2013","journal-title":"Diabetes Care"},{"issue":"8","key":"2020071619322526200_B14","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.2337\/dc13-2957","article-title":"Increased risk of fracture and postfracture adverse events in patients with diabetes: two nationwide population-based retrospective cohort studies","volume":"37","author":"Liao","year":"2014","journal-title":"Diabetes Care"},{"issue":"4","key":"2020071619322526200_B15","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2337\/db07-0715","article-title":"Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis","volume":"57","author":"Chen","year":"2008","journal-title":"Diabetes"},{"issue":"3","key":"2020071619322526200_B16","doi-asserted-by":"crossref","first-page":"2B","DOI":"10.1016\/0002-9149(85)90607-1","article-title":"Basic cellular mechanisms of action of the calcium-channel blockers","volume":"55","author":"Katz","year":"1985","journal-title":"Am J Cardiol"},{"key":"2020071619322526200_B17","doi-asserted-by":"crossref","first-page":"97S","DOI":"10.1111\/j.1365-2125.1986.tb02859.x","article-title":"Calcium antagonists and their mode of action: an historical overview","volume":"21","author":"Nayler","year":"1986","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"2020071619322526200_B18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-105-3-329","article-title":"Verapamil pharmacodynamics and disposition in young and elderly hypertensive patients. Altered electrocardiographic and hypotensive responses","volume":"105","author":"Abernethy","year":"1986","journal-title":"Ann Intern Med"},{"issue":"4","key":"2020071619322526200_B19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2125.1995.tb04554.x","article-title":"Age and gender related changes in stereoselective pharmacokinetics and pharmacodynamics of verapamil and norverapamil","volume":"40","author":"Gupta","year":"1995","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"2020071619322526200_B20","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/ajh.2011.8","article-title":"Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and diabetes: a meta-analysis of placebo-controlled clinical trials","volume":"24","author":"Tocci","year":"2011","journal-title":"Am J Hypertens"},{"issue":"4","key":"2020071619322526200_B21","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/hy1101.092970","article-title":"Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats","volume":"38","author":"Henriksen","year":"2001","journal-title":"Hypertension"},{"issue":"3","key":"2020071619322526200_B22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1161\/01.HYP.0000028979.98877.0C","article-title":"ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO","volume":"40","author":"Shiuchi","year":"2002","journal-title":"Hypertension"},{"issue":"12","key":"2020071619322526200_B23","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1097\/00004872-200412000-00003","article-title":"Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin-angiotensin system","volume":"22","author":"Kurtz","year":"2004","journal-title":"J Hypertens"},{"key":"2020071619322526200_B24","doi-asserted-by":"crossref","first-page":"f6745","DOI":"10.1136\/bmj.f6745","article-title":"Role of diuretics, \u03b2 blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study","volume":"347","author":"Shen","year":"2013","journal-title":"BMJ"},{"issue":"7","key":"2020071619322526200_B25","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4330\/wjc.v6.i7.517","article-title":"Antihypertensive drugs and glucose metabolism","volume":"6","author":"Rizos","year":"2014","journal-title":"World J Cardiol"},{"issue":"8","key":"2020071619322526200_B26","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s00125-006-0269-5","article-title":"Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control","volume":"49","author":"Nakata","year":"2006","journal-title":"Diabetologia"},{"issue":"9716","key":"2020071619322526200_B27","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"issue":"21","key":"2020071619322526200_B28","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"issue":"3","key":"2020071619322526200_B29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/01.CIR.103.3.357","article-title":"Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study","volume":"103","author":"Freeman","year":"2001","journal-title":"Circulation"},{"issue":"11","key":"2020071619322526200_B30","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jfma.2012.09.014","article-title":"Incidence and prevalence rates of diabetes mellitus in Taiwan: analysis of the 2000-2009 Nationwide Health Insurance database","volume":"111","author":"Jiang","year":"2012","journal-title":"J Formos Med Assoc"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/102\/7\/2604\/18171338\/jc.2016-3778.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/102\/7\/2604\/18171338\/jc.2016-3778.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T04:34:55Z","timestamp":1594960495000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/102\/7\/2604\/3084591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,24]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2016-3778","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,7,1]]},"published":{"date-parts":[[2017,3,24]]}}}